


文檔簡介
1、 HYPERLINK https:/www.MedChemE/Targets/YAP.html YAPYes-associated proteinYAP (Yes-associated protein) is a transcription co-activator in the Hippo tumor suppressor pathway and controls cell growth, tissuehomeostasis and organ size. YAP is inhibited by the kinase Lats, which phosphorylates YAP to ind
2、uce its cytoplasmic localizationand proteasomal degradation. YAP induces gene expression by binding to the TEAD family transcription factors.The function of YAP in human cancer is complex and could be cell-type-dependent. For instance, YAP could function as a tumorsuppressor in some cell types, such
3、 as hematological cancers, by inducing apoptosis in response to DNA damage.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/YAP.html YAP HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html Inhibitors, HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERL
4、INK https:/www.MedChemE/Targets/YAP.html Antagonists, HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html Activators HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html & HYPERLINK https:/www.MedChemE/Targets/YAP.htm
5、l HYPERLINK https:/www.MedChemE/Targets/YAP.html Modulators HYPERLINK https:/www.MedChemE/AICAR.html AICAR(Acadesine; AICA Riboside) Cat. No.: HY-13417 HYPERLINK https:/www.MedChemE/AICAR-phosphate.html AICAR HYPERLINK https:/www.MedChemE/AICAR-phosphate.html HYPERLINK https:/www.MedChemE/AICAR-phos
6、phate.html phosphate(Acadesine phosphate; AICA Riboside phosphate) Cat. No.: HY-13417AAICAR (Acadesine) is an adenosine analog and aAMPK activator. AICAR regulates the glucose andlipid metabolism, and inhibits proinflammatorycytokines and iNOS production. AICAR is also anautophagy, YAP and mitophagy
7、 inhibitor.AICAR phosphate (Acadesine phosphate) is anadenosine analog and a AMPK activator. AICARphosphate regulates the glucose and lipidmetabolism, and inhibits proinflammatory cytokinesand iNOS production. AICAR phosphate is also anautophagy, YAP and mitophagy inhibitor.Purity: 99.92%Clinical Da
8、ta: Phase 3Size: 50 mg, 100 mg, 200 mg, 500 mgPurity: 99.49%Clinical Data: Phase 3Size: 10 mM 1 mL, 50 mg, 100 mg, 200 mg, 500 mg HYPERLINK https:/www.MedChemE/cytochalasin-d.html Cytochalasin HYPERLINK https:/www.MedChemE/cytochalasin-d.html HYPERLINK https:/www.MedChemE/cytochalasin-d.html D(Zygos
9、porin A; NSC 209835) Cat. No.: HY-N6682 HYPERLINK https:/www.MedChemE/k-975.html K-975Cat. No.: HY-138565Cytochalasin D (Zygosporin A; NSC 209835) is apotent and cell-permeable inhibitor of actinpolymerization derived from fungus, inhibits theG-actincofilin interaction by binding to G-actin.K-975 is
10、 a potent, selective and orally activeTEAD inhibitor, with a strong inhibitory effectagainst protein-protein interactions betweenYAP1/TAZ and TEAD. K-975 covalently binds toCys359 located in the palmitate-binding pocket ofTEAD via an acrylamide structure.Purity: 99.75%Clinical Data: No Development R
11、eportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mgPurity: 98.55%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/lats-in-1.html Lats-IN-1 HYPERLINK https:/www.MedChemE/lats-in-1.html HYPERLINK https:/www.MedChemE/ML-7-hydrochloride.html ML-7 HYPERLI
12、NK https:/www.MedChemE/ML-7-hydrochloride.html HYPERLINK https:/www.MedChemE/ML-7-hydrochloride.html hydrochlorideCat. No.: HY-138489 Cat. No.: HY-15417Lats-IN-1 is a potent and ATP-competitiveinhibitor of Lats1 and Lats2 kinases. Lats-IN-1promotes Yap-dependent proliferation inpostmitotic mammalian
13、 tissues.ML-7 hydrochloride is a naphthalene sulphonamidederivative, potently inhibits MLCK (IC =30050nM). ML-7 hydrochloride also inhibits YAP/TAZ.Purity: 99.98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.75%Clinical Data: No Development ReportedSize: 10
14、mM 1 mL, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/myf-01-37.html MYF-01-37 HYPERLINK https:/www.MedChemE/myf-01-37.html HYPERLINK https:/www.MedChemE/py-60.html PY-60Cat. No.: HY-139603 Cat. No.: HY-141644MYF-01-37 is a covalent TEAD inhibitor targetingCys380. MYF-01-37 has a reversible inhibition
15、 onYAP/TEAD interaction.PY-60 is a robust and specific activator of YAPtranscriptional activity that targets annexin A2(ANXA2) with a K of 1.4 M. PY-60 directlydbinds to ANXA2 and antagonizes its normal cellularfunction of repressing YAP activity.Purity: 98.98%Clinical Data: No Development ReportedS
16、ize: 5 mg, 10 mg, 50 mg, 100 mgPurity: 98.63%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/super-tdu.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu.html HYPERLINK https:/www.MedChemE/super-tdu-1-31.html Super-TDU HYPER
17、LINK https:/www.MedChemE/super-tdu-1-31.html HYPERLINK https:/www.MedChemE/super-tdu-1-31.html (1-31)Cat. No.: HY-P1727 Cat. No.: HY-P1728Super-TDU is a specific YAP antagonist targetingYAP-TEADs interaction. Super-TDU suppresses tumorgrowth in gastric cancer mouse model.Super-TDU (1-31) is a peptid
18、e of Super-TDU, whichis an inhibitor of YAP-TEADs, shows potentanti-tumor activity.Purity: 98.85%Clinical Data: No Development ReportedSize: 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/
19、super-tdu-1-31-tfa.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html (1-31) HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html (TFA) HYPERLINK https:/www.MedChemE/super-t
20、du-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-tfa.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-tfa.html TFACat. No.: HY-P1728A Cat. No.: HY-P1727ASuper-TDU (1-31) is a peptide of Super-TDU, whichis an inhibitor of YAP-TEADs, shows
21、 potentanti-tumor activity.Super-TDU TFA is a specific YAP antagonisttargeting YAP-TEADs interaction. Super-TDU TFAsuppresses tumor growth in gastric cancer mousemodel.Purity: 96.04%Clinical Data: No Development ReportedSize: 1 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPE
22、RLINK https:/www.MedChemE/ted-347.html TED-347Cat. No.: HY-125269 HYPERLINK https:/www.MedChemE/Verteporfin.html Verteporfin(CL 318952) Cat. No.: HY-B0146TED-347 is a potent, irreversible, covalent andallosteric inhibitor at YAP-TEAD protein-proteininteraction with an EC of 5.9 M for TEAD4Yap150prot
23、ein-protein interaction.Verteporfin (CL 318952) is a photosensitizer forphotodynamic therapy to eliminate the abnormalblood vessels in the eye associated withconditions such as age-related maculardegeneration. Verteporfin is a YAP inhibitorwhich disrupts YAP-TEAD interactions.Purity: 98.78%Clinical
24、Data: No Development ReportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mg, 25 mg, 50 mgPurity: 99.58%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/vt103.html VT103 HYPERLINK https:/www.MedChemE/vt103.html HYPERLINK https:/www.MedChemE/vt107.html VT107Cat. N
25、o.: HY-134955 Cat. No.: HY-134957VT103, an analog of VT101, is an orally active andselective TEAD1 protein palmitoylation inhibitor.VT103 inhibits YAP/TAZ-TEAD promoted genetranscription, blocks TEAD auto-palmitoylation,and disrupts interaction between YAP/TAZ andTEAD.VT-107, as an analogous to VT10
26、4, is an orallyactive and potent pan-TEAD auto-palmitoylationinhibitor. VT-107 can be used for the research ofcancer.Purity: 99.21%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.98%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50
27、 mg, 100 mg HYPERLINK https:/www.MedChemE/yap-tead.html YAP-TEAD-IN-1 HYPERLINK https:/www.MedChemE/yap-tead.html HYPERLINK https:/www.MedChemE/yap-tead-tfa.html YAP-TEAD-IN-1 HYPERLINK https:/www.MedChemE/yap-tead-tfa.html HYPERLINK https:/www.MedChemE/yap-tead-tfa.html TFACat. No.: HY-P2244 Cat. No.: HY-P2244AYAP-TEAD-IN-1 is a potent and competitiveinhibitor of YAPTEAD interaction (IC =2550nM). YAP-TEAD-IN-1 is a 17mer pep
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 天津市一中2025屆化學高二下期末達標檢測模擬試題含解析
- 新疆伊寧生產建設兵團第四師第一中學2025屆高二數學第二學期期末質量檢測試題含解析
- 人力資源財務代理服務合同范本
- 礦山開采場地平整與土地復墾合同
- 住宅小區公共區域裝修材料采購合同
- 長期金融顧問咨詢與管理合同
- 橙色插畫風秋季健康知識模板
- 二手商品房房屋買賣簡單合同(16篇)
- 噴漆承包合同集錦(15篇)
- 二手簡裝房交易合同(4篇)
- 《糖尿病合并高血壓患者管理指南(2025版)》解讀
- 2025年4月稽陽聯誼學校高三聯考語文試題解析
- 小學生科普天文知識課件
- 胃癌手術預康復管理中國專家共識(2024版)解讀
- 2024北京豐臺區四年級(下)期末數學試題及答案
- 海南省歷年中考作文題與審題指導(2003-2023)
- 幼兒照護知到課后答案智慧樹章節測試答案2025年春鐵門關職業技術學院
- 2025至2030年多功能背封包裝機項目投資價值分析報告
- 餐廳送貨協議合同
- 競聘資產管理部部長崗位
- 2025衢州輔警考試題庫
評論
0/150
提交評論